IPP Bureau
Pharmexcil appoints Bhavin Mukund Mehta as Vice Chairman
By IPP Bureau - February 05, 2025
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment diabetes-related blindness
By IPP Bureau - February 05, 2025
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)
Somaiya Vidyavihar University to host conference on ‘Clinical Translation of Biomaterials for Future Healthcare’
By IPP Bureau - February 04, 2025
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
Hikal appoints Dr. Raghavendar Morthala as Head – CDMO R&T Pharma & Animal Health BU
By IPP Bureau - February 04, 2025
Brenntag Specialties unveils pharmaceutical and nutraceutical innovations at Vitafoods India
By IPP Bureau - February 04, 2025
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
Carbogen Amcis appoints Stephan Fritschi as CEO
By IPP Bureau - February 04, 2025
Pascal Villemagne has announced his intent to step down at the end of March 2025, to take on a new challenge in his professional career.
Akums combines two potent diabetes medicines for enhanced treatment efficacy
By IPP Bureau - February 04, 2025
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
Gland Pharma reports Q3 FY25 revenue at Rs. 1,384 Cr
By IPP Bureau - February 04, 2025
Our Q3 FY25 revenue was at Rs. 1,384.1 crore with an EBITDA of Rs. 360 crore resulting in a 26% EBITDA margin
Zydus Wellness records consolidated net sales growth of 12.7% in Q3 FY25
By IPP Bureau - February 04, 2025
EBITDA rose to Rs. 14.8 crore, marking a 16.5% y-o-y increase, while net profit surged to Rs. 6.4 crore
Sigachi Industries to invest US $1 mn in establishing R&D Centre in Hyderabad
By IPP Bureau - February 04, 2025
The company is committed to revolutionizing API development by advancing synthesis and analytical processes that enhance quality and impact lives
Lupin announces closure of USFDA inspection at its Somerset facility with zero 483 observations
By IPP Bureau - February 03, 2025
The inspection was carried out from January 28 to February 1, 2025
CuraTeQ Biologics receives positive opinion for biosimilar Dyrupeg from EMA
By IPP Bureau - February 03, 2025
Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the duration of neutropenia
Jubilant Pharmova Q3 FY25 revenue up 9%
By IPP Bureau - February 03, 2025
EBITDA grew by 11% on a YoY basis to Rs. 296 crore due to improved performance in CDMO Sterile Injectables, CRDMO and Generics
Wockhardt’s Zaynich achieves highest-ever efficacy meeting superiority in a global, pivotal, registration- enabling Phase III study
By IPP Bureau - February 03, 2025
Such combined efficacy (achieving clinical cure and microbiologic cure) of Zaynich is highest ever among all the FDA-approved novel antibiotics developed in the last more than 10 years
Nectar Lifesciences posts Q3 FY25 PAT at Rs. 7.84 Cr
By IPP Bureau - February 03, 2025
Revenue from Operations for Q3 FY25 was Rs. 454.33 crore,
